Article Information
History
- April 1, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Michael J. Sikorski1,2,3,
- Jianguo Ma4,
- Tracy H. Hazen1,3,
- Sachin N. Desai2,
- Siaosi Tupua5,
- Susana Nimarota-Brown5,
- Michelle Sialeipata5,
- Savitra Rambocus6,
- Susan A. Ballard6,
- Mary Valcanis6,
- Robert E. Thomsen5,
- Roy M. Robins-Browne6,
- Benjamin P. Howden6,
- Take K. Naseri5,
- Myron M. Levine1,2,3,† and
- David A. Rasko1,3,*
- 1Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, United States
- 2Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, United States
- 3Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, United States
- 4Department of Geographical Sciences, University of Maryland, College Park, Maryland, United States
- 5Ministry of Health, Government of Samoa, Apia, Samoa
- 6Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia